Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about TCR2 Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    TCR2 THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    TCR2 Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Binney Street, Suite 710 Cambridge, MA 02142
    Telephone
    Telephone
    617.949.5200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tcr2.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2023/05/08/2663841/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2023
    Share Share
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2023/04/03/2640162/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Apr 2023
    Share Share
    TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results
    TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results

    https://www.globenewswire.com/news-release/2023/03/23/2632946/0/en/TCR-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    23 Mar 2023
    Share Share
    Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company
    Adaptimmune & TCR² Announce Combination to Create Cell Therapy Company

    https://www.globenewswire.com/news-release/2023/03/06/2620800/0/en/Adaptimmune-and-TCR-Therapeutics-Announce-Strategic-Combination-to-Create-a-Preeminent-Cell-Therapy-Company-for-Solid-Tumors.html

    GLOBENEWSWIRE
    06 Mar 2023
    Share Share
    TCR2 Therapeutics to Present at SVB Securities Global Biopharma Conference 2023
    TCR2 Therapeutics to Present at SVB Securities Global Biopharma Conference 2023

    https://www.globenewswire.com/news-release/2023/02/08/2603758/0/en/TCR-Therapeutics-to-Present-at-SVB-Securities-Global-Biopharma-Conference-2023.html

    GLOBENEWSWIRE
    08 Feb 2023
    Share Share
    TCR² first began layoffs back in August
    TCR² first began layoffs back in August

    https://www.fiercebiotech.com/biotech/scoop-tcr2-therapeutics-just-laid-40-its-staff-its-second-round-cuts-less-six-months

    Max Bayer FIERCE BIOTECH
    13 Jan 2023
    Share Share
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

    https://www.globenewswire.com//news-release/2023/01/05/2584129/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Jan 2023
    Share Share
    TCR² Therapeutics Announces Pipeline Priorities for 2023
    TCR² Therapeutics Announces Pipeline Priorities for 2023

    https://www.globenewswire.com//news-release/2023/01/05/2583769/0/en/TCR-Therapeutics-Announces-Pipeline-Priorities-for-2023.html

    GLOBENEWSWIRE
    05 Jan 2023
    Share Share
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule
    TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule

    https://www.globenewswire.com//news-release/2022/12/01/2566340/0/en/TCR-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Dec 2022
    Share Share
    TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference
    TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference

    https://www.globenewswire.com//news-release/2022/11/23/2561475/0/en/TCR-Therapeutics-to-Present-at-the-Piper-Sandler-Healthcare-Conference.html

    GLOBENEWSWIRE
    23 Nov 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search